Effects of 4 weeks supplementation with a multi-vitamin/mineral preparation on neurocognitive function in healthy adults
Phase 3
Completed
- Conditions
- MoodCognitive Function
- Registration Number
- ACTRN12617000305325
- Lead Sponsor
- Swinburne University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the neurocognitive effects of multi-vitamin/mineral supplementation in healthy adults?
How does multi-vitamin/mineral supplementation compare to standard-of-care treatments for cognitive enhancement in adults with mood disorders?
Are there specific biomarkers that predict neurocognitive response to multi-vitamin/mineral supplementation in phase III trials?
What are the potential adverse events associated with 4-week multi-vitamin/mineral supplementation in healthy populations?
What related compounds or combination therapies have been studied for neurocognitive improvement in healthy adults alongside multi-vitamin/mineral supplements?